These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 467492

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
    Lotzová E, Savary CA, Stringfellow DA.
    J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
    [Abstract] [Full Text] [Related]

  • 7. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F, Peri G, Villa A, Mantovani A.
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 10. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM, Gallimore PH, Zimmer SG, Sopori ML.
    J Immunol; 1984 Mar 15; 132(3):1578-82. PubMed ID: 6319497
    [Abstract] [Full Text] [Related]

  • 11. Enhanced lytic susceptibility of Ha-ras transformants after oncogene induction is specific to activated NK cells.
    Johnson PW, Trimble WS, Hozumi N, Roder JC.
    J Immunol; 1987 Jun 01; 138(11):3996-4003. PubMed ID: 3495578
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of loss of natural killer activity in P815 ascites tumor bearing DBA/2 mice.
    Saxena RK, Saxena QB, Adler WH.
    Nat Immun Cell Growth Regul; 1987 Jun 01; 3(1):34-42. PubMed ID: 6235448
    [Abstract] [Full Text] [Related]

  • 13. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ, Taramelli D, Holden HT, Varesio L.
    J Immunol; 1983 Apr 01; 130(4):1974-9. PubMed ID: 6187831
    [Abstract] [Full Text] [Related]

  • 14. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
    Kalland T, Alm G, Stålhandshe T.
    J Immunol; 1985 Jun 01; 134(6):3956-61. PubMed ID: 2580900
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998 Jun 01; 10(10):483-9. PubMed ID: 10338151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.
    Rolstad B, Benestad HB.
    Immunology; 1991 Sep 01; 74(1):86-93. PubMed ID: 1937576
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.